Zai Lab (STU:1ZLB) ROE % Adjusted to Book Value : -12.92% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Zai Lab ROE % Adjusted to Book Value?

Zai Lab's ROE % for the quarter that ended in Dec. 2024 was -44.43%. Zai Lab's PB Ratio for the quarter that ended in Dec. 2024 was 3.44. Zai Lab's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -12.92%.

Zai Lab ROE % Adjusted to Book Value Historical Data

The historical data trend for Zai Lab's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zai Lab ROE % Adjusted to Book Value Chart

Zai Lab Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-0.38

-1.34

-13.16

-11.10

-9.31

Zai Lab Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-13.98	-13.22	-19.22	-6.59	-12.92

Competitive Comparison of Zai Lab's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Zai Lab's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zai Lab's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zai Lab's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Zai Lab's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Zai Lab ROE % Adjusted to Book Value Calculation

Zai Lab's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-32.03%	/	3.44
	=	-9.31%

Zai Lab's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-44.43%	/	3.44
	=	-12.92%

Zai Lab ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Zai Lab's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Zai Lab Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zai Lab Ltd (STU:1ZLB) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ZLAB:USA ZLAB N:Mexico 09688:Hong Kong 1ZLB:Germany 1ZL:Germany 1ZL:Germany

Address

4560 Jinke Road, Jinchuang Plaza, Building 1, 4th Floor, Pudong, Shanghai, CHN, 201210

Website

https://www.zailaboratory.com

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Zai Lab Headlines

No Headlines